Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger D Weiss

Showing results (21-30 of 271) with videos related to

Pageof 28
Sort By:
Current Psychiatry Reports|August 22, 2012
Treatment of the depressed alcoholic patientJeffrey J DeVido, Roger D Weiss
The American Journal of Psychiatry|December 17, 2016
The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A ReviewKathleen M Carroll, Roger D Weiss
The American Journal of Psychiatry|October 2, 2018
Microscopes and Telescopes: the Societal Impact of Substance Use Disorder TreatmentHilary S Connery, Roger D Weiss
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|May 8, 2012
Recovery of cognitive functioning in patients with co-occurring bipolar disorder and alcohol dependence during early remission from an acute mood episodeBoaz Levy, Emily Manove, Roger D Weiss
Harvard Review of Psychiatry|March 10, 2015
Alcohol use disorders in pregnancyJeffrey DeVido, Olivera Bogunovic, Roger D Weiss
Comprehensive Psychiatry|January 30, 2013
Cognitive and psychosocial functioning in bipolar disorder with and without psychosis during early remission from an acute mood episode: a comparative longitudinal studyBoaz Levy, Anna Marie Medina, Roger D Weiss
The American Journal on Addictions|March 18, 2014
Cue-induced craving in dependence upon prescription opioids and heroinR Kathryn McHugh, Sara Park, Roger D Weiss
BMJ (Clinical Research Ed.)|August 16, 2022
Is daily supervised buprenorphine-naloxone dosing necessary?Robert A Kleinman, Suzanne Nielsen, Roger D Weiss
The American Journal on Addictions|April 9, 2008
Physical pain and associated clinical characteristics in treatment-seeking patients in four substance use disorder treatment modalitiesJennifer Sharpe Potter, Kristi Prather, Roger D Weiss
JAMA Psychiatry|February 12, 2025
Strengthening Safeguards for Psychiatric Uses of KetamineBrian S Barnett, Roger D Weiss, Gerard Sanacora
Pageof 28

Showing results (21-30 of 271) with videos related to

Sort By:
Pageof 28
Current Psychiatry Reports|August 22, 2012
Treatment of the depressed alcoholic patientJeffrey J DeVido, Roger D Weiss
The American Journal of Psychiatry|December 17, 2016
The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A ReviewKathleen M Carroll, Roger D Weiss
The American Journal of Psychiatry|October 2, 2018
Microscopes and Telescopes: the Societal Impact of Substance Use Disorder TreatmentHilary S Connery, Roger D Weiss
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|May 8, 2012
Recovery of cognitive functioning in patients with co-occurring bipolar disorder and alcohol dependence during early remission from an acute mood episodeBoaz Levy, Emily Manove, Roger D Weiss
Harvard Review of Psychiatry|March 10, 2015
Alcohol use disorders in pregnancyJeffrey DeVido, Olivera Bogunovic, Roger D Weiss
Comprehensive Psychiatry|January 30, 2013
Cognitive and psychosocial functioning in bipolar disorder with and without psychosis during early remission from an acute mood episode: a comparative longitudinal studyBoaz Levy, Anna Marie Medina, Roger D Weiss
The American Journal on Addictions|March 18, 2014
Cue-induced craving in dependence upon prescription opioids and heroinR Kathryn McHugh, Sara Park, Roger D Weiss
BMJ (Clinical Research Ed.)|August 16, 2022
Is daily supervised buprenorphine-naloxone dosing necessary?Robert A Kleinman, Suzanne Nielsen, Roger D Weiss
The American Journal on Addictions|April 9, 2008
Physical pain and associated clinical characteristics in treatment-seeking patients in four substance use disorder treatment modalitiesJennifer Sharpe Potter, Kristi Prather, Roger D Weiss
JAMA Psychiatry|February 12, 2025
Strengthening Safeguards for Psychiatric Uses of KetamineBrian S Barnett, Roger D Weiss, Gerard Sanacora
Pageof 28